Additionally, we documented that convalescent COVID-19 subjects with systemic inflammation and increased serum levels of circulating IL-6 may benefit more in terms of endothelium-dependent vasodilation from a rehabilitation program. The gene discussed is IL6; the disease is COVID-19.